Respiri Limited Clinches A$1.6 Million Investment
Company Announcements

Respiri Limited Clinches A$1.6 Million Investment

Respiri Limited (AU:RSH) has released an update.

Respiri Limited has successfully raised A$1.6 million through a strategic placement, welcoming Merchant Biotech Fund and Hamma Capital among other investors to its registry. This capital boost, complemented by recent strategic agreements and operational successes, positions the eHealth company for accelerated revenue growth and a confident stride towards profitability in the US market. The investment, at a 4% premium over the 10-day VWAP, underscores investor confidence in Respiri’s US strategy and its innovative remote patient monitoring solutions.

For further insights into AU:RSH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskRespiri Limited Updates AGM Resolutions and Proxy Forms
TipRanks Australian Auto-Generated NewsdeskRespiri Limited Targets Growth Amid Regulatory Gains
TipRanks Australian Auto-Generated NewsdeskRespiri Limited Poised for Growth with AMA’s Support
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App